Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Shenzhen Hepalink Pharmaceutical Co.,Ltd..

    Client Virtual Booth

    SHENZHEN HEPALINK PHARMACEUTICAL CO.,LTD.

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Shenzhen Hepalink Pharmaceutical Co.,Ltd.
    China Flag
    Country
    Country
    China
    Address
    Address
    Shenzhen Hepalink Pharmaceutical Co., Ltd. 21 Langshan Road, Songpingshan, Nanshan District, Shenzhen 518057
    Telephone
    Telephone
    +86-755-26980200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.hepalink.com/en/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    OncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovom...

    Details:

    Under the agreement, OncoVent agreed to grant exclusive rights to OEP, which will be responsible for the commercialization of MAb-B43.13 (oregovomab), an immunotherapy drug candidate, in Taiwan, including related regulatory applications and necessary clinical trials.


    Lead Product(s): Oregovomab,Paclitaxel,Carboplatin

    Therapeutic Area: Oncology Product Name: MAb-B43.13

    Highest Development Status: Phase IIIProduct Type: Large molecule

    Partner/Sponsor/Collaborator: Orient EuroPharma

    Deal Size: $11.2 million Upfront Cash: Undisclosed

    Deal Type: Licensing Agreement March 28, 2023

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search